Charles River Laboratories International (FRA:RV6) Accounts Payable: €123 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RV6 Charles River Laboratories International Inc FRA:RV6
69 GF Score
Price €242.50
GF Value €164.19
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Charles River Laboratories International Accounts Payable?

Charles River Laboratories International FRA:RV6 +2.26% 69 Accounts Payable is €123 Mil as of Jun. 2026. GuruFocus rates FRA:RV6 with a GF Score™ of 69/100 and a GF Value™ of €164.19 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Charles River Laboratories International's Accounts Payable for the quarter that ended in Jun. 2026 was €123 Mil.

Charles River Laboratories International's quarterly Accounts Payable declined from Dec. 2025 (€127 Mil) to Mar. 2026 (€116 Mil) but then increased from Mar. 2026 (€116 Mil) to Jun. 2026 (€123 Mil).

Charles River Laboratories International's annual Accounts Payable declined from Dec. 2023 (€153 Mil) to Dec. 2024 (€136 Mil) and declined from Dec. 2024 (€136 Mil) to Dec. 2025 (€127 Mil).

Charles River Laboratories International Accounts Payable Related Terms

Charles River Laboratories International Accounts Payable Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Accounts Payable Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 174.23 192.94 152.93 135.53 126.70

Charles River Laboratories International Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.20 144.35 126.70 116.26 123.31
FRA:RV6
69GF Score
Charles River Laboratories International Inc FRA:RV6
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €123 Mil mean?
Charles River Laboratories International (FRA:RV6) has a Accounts Payable of €123 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Charles River Laboratories International and its competitors.
Is Charles River Laboratories International's Accounts Payable too high?
Charles River Laboratories International's current Accounts Payable is €123 Mil. Overall, Charles River Laboratories International has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Accounts Payable compare to RVTY and ICLR?
Charles River Laboratories International's Accounts Payable of €123 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current Accounts Payable is €123 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Based on GuruFocus' analysis, Charles River Laboratories International (FRA:RV6) is currently considered Significantly Overvalued. The stock's GF Value™ is €164.19, compared to a current price of €242.50 — trading 47.7% above its estimated fair value. The current Accounts Payable is €123 Mil. Charles River Laboratories International's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Charles River Laboratories International (FRA:RV6), the current Accounts Payable is €123 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (FRA:RV6) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €242.50 is trading 47.7% above its estimated GF Value™ of €164.19. GuruFocus considers Charles River Laboratories International to be Significantly Overvalued.

Key valuation signals for FRA:RV6:

  • Accounts Payable: €123 Mil
  • GF Value™: €164.19 vs. price of €242.50 (47.7% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the FRA:RV6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Charles River Laboratories International Business Description

Other Exchanges CRL:USA
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories International Inc. is a US-based contract research organization serving pharmaceutical, biotechnology, government, and academic institutions worldwide. The company operates through three reportable segments: Research Models and Services, which breeds and supplies laboratory animals, including genetically modified models, and offers associated services such as insourcing and pathology; Discovery and Safety Assessment, which provides nonclinical drug discovery and development services, including toxicology, safety pharmacology, and bioanalysis; and Manufacturing Solutions, which supplies microbial detection and identification products, endotoxin testing, biologics safety testing, and cell and gene therapy support services. Revenue is generated primarily through service contracts and product sales tied to clients' research and development spending. Charles River operates facilities across North America, Europe, and Asia, supporting preclinical and clinical-stage programs from early discovery through manufacturing quality control.
69GF Score

Get the complete analysis for FRA:RV6

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€242.50
Price
€164.19
GF Value